Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023

NHS England

This public procurement record has 1 release in its history.

Award

24 Mar 2023 at 11:46

Award Notice
Summary of the contracting process

The NHS England has recently awarded a National Framework Agreement for the supply of Adalimumab Injection with a total value of £264,003,000. The procurement stage was an open procedure above the threshold, with a tender period ending on 28th November 2022. The contract period covers 1st April 2023 to 28th February 2026. The industry category is Pharmaceutical products, and the contract was awarded on 3rd March 2023.

This tender presents significant business opportunities for suppliers in the pharmaceutical industry who specialize in the supply of Adalimumab Injection. Small and medium-sized enterprises (SMEs) can benefit from this framework agreement, as it involves multiple regions across the UK. Businesses with experience in large-scale pharmaceutical supply contracts are well-suited to compete in this procurement process, paving the way for sustainable business growth and expansion.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023

Notice Description

Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023 Offer reference number: CM/PHR/22/5660 CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/a6b9f437-01c6-49a7-a10f-e629b7cdf660
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£264,003,000 £100M-£1B
Lots Value
Not specified
Awards Value
£264,003,228 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
24 Mar 20233 years ago
Submission Deadline
28 Nov 2022Expired
Future Notice Date
Not specified
Award Date
3 Mar 20233 years ago
Contract Period
1 Apr 2023 - 28 Feb 2026 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
6
Supplier Names

Abbvie Ltd

Amgen Ltd

Biogen

Celltrion Healthcare United Kingdom Limited

Fresenius Kabi Limited

Sandoz Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...